Drugs / Rotavirus RV3 Vaccine (Bio Farma)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04185545 | Oct 2020 → Apr 2022 | Rotavirus infection | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotavirus RV3 Vaccine (Bio Farma) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04185545 ↗ |
| Modality | Vaccine | “oral liquid rotavirus vaccine” NCT04185545 ↗ |
| Route | Oral | “3 oral doses of RV3 vaccine (Bio Farma) batch 1; administered at 0-5 days, 8-10 weeks, and 12-14 weeks of age.” NCT04185545 ↗ |